norleucine has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begeot, M; Blondet, A; Gout, J; Mithieux, G; Naville, D; Rajas, F; Sarafian, D; Tirard, J; Vigier, M | 1 |
| Bewley, MC; Cheng, KC; Flanagan, JM; Griffin, K; Homanics, GE; Lanoue, KF; Lazovic, J; Paul, HS; Skvorak, KJ; Zinnanti, WJ | 1 |
| Lazovic, J; Zinnanti, WJ | 1 |
1 review(s) available for norleucine and Disease Models, Animal
| Article | Year |
|---|---|
Interrupting the mechanisms of brain injury in a model of maple syrup urine disease encephalopathy.
Topics: Animals; Brain Diseases; Brain Edema; Brain Injuries; Disease Models, Animal; Glucose; Humans; Maple Syrup Urine Disease; Mice; Mice, Knockout; Models, Biological; Norleucine | 2012 |
2 other study(ies) available for norleucine and Disease Models, Animal
| Article | Year |
|---|---|
Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.
Topics: Agouti-Related Protein; alpha-MSH; Animals; Cell Line; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypothalamus; Infusions, Parenteral; Leptin; Male; Melanocortins; Mice; Mice, Inbred C57BL; Norleucine; Obesity; Pro-Opiomelanocortin; Receptor, Melanocortin, Type 4; RNA, Messenger | 2008 |
Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
Topics: Amino Acids; Animals; Behavior, Animal; Brain; Brain Edema; Brain Mapping; Dietary Proteins; Disease Models, Animal; Drug Evaluation, Preclinical; Growth Disorders; Keto Acids; Magnetic Resonance Imaging; Maple Syrup Urine Disease; Mice; Mice, Knockout; Norleucine; Survival Analysis | 2009 |